Plain-English translation of NCT07362017 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This is a research study testing a medication called to see if it can safely and effectively treat moderate-to-severe plaque psoriasis (a skin condition that causes thick, red, scaly patches). Researchers want to understand how well this treatment works and whether it causes any side effects. About 300 people will participate across multiple medical centers.
Moderate-to-severe psoriasis can be difficult to treat and significantly affect quality of life. This medication may offer a new option for people who need better control of their symptoms.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will take as prescribed and visit the study center regularly so doctors can check how your skin is responding and monitor for any side effects. The study team will assess your psoriasis using standard measures and ask you about your experience. Your exact schedule will be explained when you join, but you can expect multiple clinic visits over the course of the trial.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
United States